Skip to content
OpenCapital
Get started
Bruker logo

Bruker

BRKR

Bruker Corporation is a global developer and manufacturer of high-performance scientific instruments and analytical solutions used to explore life and materials at microscopic and molecular levels.

Market cap
$8.71B+35.4%
Revenue$3.5B+0.4%
Net income-$20.2M-118%
Free cash flow$51.3M-70.6%
EPS (diluted)-$0.23-130%
Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026
Revenue$823.4MBeat by $27.8MEPS$0.31Beat by $0.08

Next report

Aug 4, 2026 (In 3 weeks)
Revenue estimate$853.6M
EPS estimate$0.38

Financials

Q1 2026

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation & ratios

Valuation

See full
Market cap$8.71B+35.4%
Enterprise value$10.24B+16.8%
P/S2.5×+0.7×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Segments

By segment

See full
Bsi Calid$316.3M+12.9%
Bsi Nano$246.0M-4.1%
Bsi Biospin$197.5M-5.0%
Energy And Supercon Technologies$66.8M+12.6%

By geography

See full
Europe Excluding Germany$258.9M—
Asia Pacific Excluding China$134.7M—
Other Country$71.2M+7.6%

Competitors

By market cap

Thermo Fisher Scientific logo
Thermo Fisher Scientific$189.58B+17.0%
Danaher logo
Danaher$135.02B-7.2%
Agilent Technologies logo
Agilent Technologies$36.5B+5.7%
WAT
Waters Corporation$36.1B+73.4%
TEC
Bio-Techne$11.1B+32.7%
Bruker logo
Bruker$8.7B+35.4%
10x Genomics, Inc. logo
10x Genomics, Inc.$4.8B+197%
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.$566.9M+19.0%

By revenue growth

WAT
Waters Corporation+26.4%
Agilent Technologies logo
Agilent Technologies+9.1%
Danaher logo
Danaher+4.0%
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.+3.6%
Thermo Fisher Scientific logo
Thermo Fisher Scientific+2.4%
10x Genomics, Inc. logo
10x Genomics, Inc.+2.3%
Bruker logo
Bruker+0.4%
TEC
Bio-Techne+0.2%

By net margin

Agilent Technologies logo
Agilent Technologies19.55%+2.0pp
Thermo Fisher Scientific logo
Thermo Fisher Scientific15.19%+0.4pp
Danaher logo
Danaher14.89%-0.9pp
WAT
Waters Corporation11.91%-10.1pp
TEC
Bio-Techne10.89%-0.7pp
Bruker logo
Bruker-0.608%-3.9pp
10x Genomics, Inc. logo
10x Genomics, Inc.-3.55%+21.6pp
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.-36.25%-22.5pp

Profile

Bruker Corporation is a global developer and manufacturer of high-performance scientific instruments and analytical solutions used to explore life and materials at microscopic and molecular levels. The company provides essential technology for structural biology, proteomics, and nanotechnology research, enabling customers to detect and visualize chemical and biological characteristics. Its value proposition centers on driving innovation and productivity in life science research, biopharmaceuticals, and clinical diagnostics.

Competitive position

A leading global provider of high-end analytical instrumentation with a dominant position in magnetic resonance and high-field NMR technologies.

GeographiesNorth America, Europe, China, Japan, Asia Pacific
Customer segmentsAcademic and Government Research, Pharmaceutical and Biotech, Clinical Diagnostics, Industrial and Applied Markets
Business modelManufacturing, Direct Sales, Aftermarket Services, Consumables and Reagents
SuppliersNiobium-based raw materials, Ceramics, X-ray tubes, Robotics, Infrared optics, CCD area detectors
CustomersAcademic researchers, Biopharmaceutical R&D labs, Clinical microbiology labs, Semiconductor quality control units, Forensic laboratories
CountryUnited States of America
Listed2000
Employees9.7K
CEOFrank H. Laukien
SectorHealthcare
IndustryMedical - Devices
Websitebruker.com
FilingsSEC EDGAR

Questions, answered.

What is Bruker's market cap?
Bruker (BRKR) has a market capitalization of $8.7B and trades on NASDAQ.
What is Bruker's revenue and profitability?
Bruker generated $3.5B in trailing twelve-month revenue with a net loss of $20.2M, representing a net margin of -0.6%. Gross margin stands at 45.3%, with free cash flow of $51.3M. These figures are based on the Q1 2026 filing.
Who are Bruker's competitors?
Bruker's key competitors include Bio-Techne, Danaher Corporation, Thermo Fisher Scientific, and others. These companies compete in similar markets and product categories.
Who does Bruker partner with?
Bruker's notable partners include Allegheny Technologies Incorporated, Biognosys, Preomics.
What subsidiaries does Bruker have?
Bruker's subsidiaries include ELITechGroup, Recipe Chemicals + Instruments GmbH, AST Revolution, LLC, and others.
Where is Bruker headquartered?
Bruker is headquartered in United States of America and employs approximately 9,707 people. It has been publicly traded since 2000.